Tajinderpal Saraon, M.D.
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) with New York University, practicing in New York, New York. Their prescriptions cost Medicare Part D more than their services did: $395,051 for 1,370 claims, against $84,775 paid for services in 2024. Abbott Laboratories was the largest of 9 companies reporting payments in 2025, $2,215 in all, mostly food and beverage. Lists NYU Langone Hospitals as a hospital affiliation.
Overview
| NPI | 1235312331 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Dec 11, 2007 |
| Last updated in NPPES | Mar 23, 2021 |
| Certified by provider | Mar 23, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 250938 | NY |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 036131330 | IL |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
| Internal Medicine | 207R00000X | 250938 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (NJ); Practitioner - Advanced Heart Failure and Transplant Cardiology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 276 |
|---|---|
| Services billed | 970 across 30 procedure codes |
| Paid by Medicare | $84,775 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,370 · 2,826 30-day fills |
|---|---|
| Patients | 182 |
| Total drug cost | $395,051 |
| Generic share | 71% of claims |
Education and affiliations
| Graduation year | 2004 |
|---|---|
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- New York UniversityNew York, NY · 6,134 clinicians
Hospital affiliation
- NYU Langone HospitalsNew York, NY
Other facilities
- Rusk RehabilitationInpatient rehabilitation facility · New York, NY
Industry payments (Open Payments)
- 2025$2,215 · 40 payments from 9 companies
- 2024$5,128 · 44 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbott Laboratories | $1,717 | 21 |
| Alnylam Pharmaceuticals Inc. | $134.76 | 1 |
| Pfizer Inc. | $117.95 | 6 |
| Merck Sharp & Dohme LLC | $64.51 | 3 |
| Endotronix, Inc. | $48.79 | 3 |
What the 2025 payments were for
- Food and Beverage$1,265 · 38 payments
- Consulting Fee$950.00 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York
- 1023351541
- 1043417157
- 1043699614
- 1053706325
- 1063775419
- 1073994208
- 1134354723
- 1174524474
- 1184864621
- 1194879825
- 1225115082
- 1265009047
All 60 Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York · All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York